Research Sample bioBank

Small Cell Lung Cancer (SCLC) Clinical Research Samples

Discovery Life Sciences provides the highest quality Small Cell Lung Cancer (SCLC) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Small Cell Lung Cancer (SCLC) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 7 of 7 total samples
 (0)
Checkout
Advanced Data View:
Showing 7 of 7 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Test 3Test Data 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Information 5Additional Data 5Additional Information 6Additional Data 6Additional Information 7Additional Data 7
DLS0068139-SSmall Cell Lung Cancer (SCLC)USASerum1.009.00$150.0060 YFU/A<-70C27-Nov-18StagingIV12-Oct-18$150.00Height | Weight168cm | 82.1kgSmoking History Previous, 25-pack-yearsDate of Initial Primary Tumor Diagnosis3/23/2018Site of Primary TumorProstateHistory of Benign Disease prior to Cancer DiagnosisDiabetes type ISite of MetastasisBrain, bilateral adrenal glands, mediastinum, right hilumCurrent MedicationsAspirin, ativan, medical marijuana, mirtazapine, novolin, oxycodone, prochlorperazine
KHBR19-00057Small Cell Lung Cancer (SCLC)USASerum1.501.00$150.0071 YFWhite<-70C04-Feb-19ResultSmall Cell Lung Cancer$150.00Freeze Date2/28/2019chemo/immuno therapy
DLS0068127-SSmall Cell Lung Cancer (SCLC)USASerum1.009.00$250.0051 YFWhite<-70C12-Dec-18Clinical DiagnosisSmall Cell Lung CancerDate of Initial Primary Tumor Diagnosis2018Site of Primary TumorMediastinum$250.00Site of MetastasisN/AHistory of Benign Disease Prior to Cancer Diagnosis?Depression, migraines, hypothyroidismAny Previous Form of Cancer?NoMost Recent StagingIIIABiomarker Testing InformationN/ASmoking HistoryCurrent; 37-pack-yearsCurrent MedicationsDexamethasone, fluoxetine, levothyroxine, medical marijuana, ondansteron, oxycodone, spiriva respimat, ventolin HFA
DLS0068135-SSmall Cell Lung Cancer (SCLC)USASerum1.006.00$250.0077 YFWhite<-70C01-Dec-18Clinical DiagnosisSmall cell lung cancer of central right lungDate of Initial Primary Tumor Diagnosis2018Site of Primary TumorCentral right lung$250.00Site of MetastasisN/AHistory of Benign Disease Prior to Cancer Diagnosis?COPD, Hypertension, CADAny Previous Form of Cancer?NoMost Recent StagingpT4N2M0 Stage IIIBBiomarker Testing InformationN/ASmoking HistoryPrevious; Years: unknown PPD: unknownCurrent Medicationsaspirin, cleareyes, dexamethason, flovent, isosorbide mononitrate, metoprolol succinate, olanzapine, oxygen, servent diskus, ventolin
DLS0068161-SSmall Cell Lung Cancer (SCLC)USASerum1.009.00$250.0062 YMWhite<-70C10-Jan-19Clinical DiagnosisSmall cell lung cancer Date of Initial Primary Tumor Diagnosis2017Site of Primary TumorUpper lobe of left lung$250.00Site of MetastasisMalignant pleural effusionHistory of Benign Disease Prior to Cancer Diagnosis?actinic keratosis, lyme disease, arthralgias in right shoulder, hemorrhoids, increased lipidsAny Previous Form of Cancer?NoMost Recent StagingStage IV T4N3M1aBiomarker Testing InformationN/ASmoking HistoryPrevious; Years: 40 PPD: 1Current Medicationslorazepam, oxycodone, oxycontin, prochlorperazine, zofran
DLS0068132-SSmall Cell Lung Cancer (SCLC)USASerum1.006.00$150.0057 YFWhite<-70C29-Jan-19Clinical DiagnosisSmall Cell Lung CancerDate of Initial Primary Tumor Diagnosis2019Site of Primary TumorRight Middle Lobe$150.00Site of MetastasisLymph nodesHistory of Benign Disease Prior to Cancer Diagnosis?Hypertension, AfibAny Previous Form of Cancer?Breast 2009Most Recent StagingStage IIIC T4N3M0Biomarker Testing InformationN/ASmoking HistoryCurrent; 20-pack-yearsCurrent MedicationsClonidine, prochlorperazine, doxycycline monohydrate, guaifenesin, xarelto, hydroxyzine hydrochloride, metoprolol tartrate, ondansetron
DLS0098452Small Cell Lung Cancer (SCLC)USASerum1.009.00$150.0071 YMWhite<-70C28-May-19Clinical DiagnosisSCLC of Right upper lobeDate of Initial Primary Tumor Diagnosis2019Site of Primary TumorRight upper lobe lung$150.00Site of MetastasisNAHistory of Benign Disease Prior to Cancer Diagnosisfacial (cheek) cellulitis, depression, hyperlipidemia, BPH, rosacea, hydrocele, PTSD, hypertensino, insomnia, bilateral cercumen impactionAny Previous Form of CancerColon Cancer, Kidney CancerStagingStage IIIA cT3cN1cM0Biomarker Testing InformationU/ASmoking HistoryPrevious; Packs Per Day: <1/2 | YRS: 53Current Medicationsamlodipine, aspirin, enteric coated, centrum silver mens, clonazeam, fluoxetine, furosemide, medical marijuana, trazodone, metoprolol tartrate, metronidazole, ondansetron, prochlorperazine, simvastatin, sodium chloride, tamsulsin

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.